Incidental findings
A Second Unrelated Cancer — Found on PET-CT
Finding a bright area in an unexpected part of your body on a PET-CT scan is frightening. It may be a second cancer, entirely unrelated to the one being treated. The next step is confirming it — not assuming the worst from one scan alone.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
- Not yet a diagnosis — A PET-CT finding is a signal, not a confirmed cancer. Tissue or further imaging is needed before anything is certain.
- Not spread of the first cancer — A second primary tumour is biologically unrelated to your first cancer — it is a separate disease, not a metastasis.
- It changes the treatment plan — Both cancers will need to be considered together, and treatment may be sequenced or combined depending on the types involved.
- Your team will coordinate the response — A finding like this almost always goes to a multidisciplinary team meeting before any new plan is made.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
A PET-CT can show an unexpected bright area in a part of the body unrelated to your known cancer. This may be a second primary tumour — a separate cancer, not the first one spreading. It needs confirmation through biopsy or additional imaging before any diagnosis is made, and your oncology team will coordinate both investigations together.
PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad, with no hidden charges. Indicative price, as of September 2026.
What do these terms mean?
- Second primary tumour
- A cancer that arises independently in a different organ or tissue from your first cancer. It is biologically separate — not the same disease extending into new territory — and is staged and treated as a new diagnosis in its own right.
- Synchronous second primary
- Two independent primary cancers found at roughly the same time. The word 'synchronous' describes when they were discovered, not any biological link between them. One cancer did not cause the other.
- Incidental finding
- Something the scan was not specifically looking for. PET-CT surveys the whole body, so it can detect activity in organs and tissues outside the region being staged. This is not an error — it is the scan working as intended.
- SUV (standardised uptake value)
- A number in your PET-CT report describing how actively a tissue is absorbing the radiotracer. Higher values are associated with faster-growing cells, but elevated SUV alone does not confirm cancer. Infection and inflamed tissue also produce high uptake.
- Multidisciplinary team (MDT)
- A meeting of oncologists, radiologists, pathologists, and surgeons who review your case together. A second primary finding almost always goes to an MDT before any new treatment decision is made.
What will your team do next?
- Your oncologist will review the radiologist's report, usually at your next appointment or sooner if the finding appears urgent.
- Additional imaging — such as a CT with contrast or an MRI — may be ordered to characterise the new lesion more clearly.
- A biopsy of the new lesion may be recommended to confirm whether it is malignant and to identify the cell type.
- The case will typically go to a multidisciplinary team (MDT) meeting before any new treatment plan is started.
- If a second cancer is confirmed, it will be staged separately so that both cancers can be managed with the right treatments.
- Your oncologist will discuss sequencing — which cancer is treated first, and whether plans for both can run concurrently.
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What does finding a second cancer change?
It changes the treatment plan — sometimes significantly. Two cancers in the same person are each staged and treated as separate diagnoses, with their own treatment intent.
The order in which they are treated depends on which is more advanced, which is more immediately urgent, and whether the treatments for one are compatible with the treatments for the other.
It does not automatically mean a worse overall situation. Each cancer is assessed on its own merits, and your team's plan will reflect both together.
How often this happens is not a figure that can be given reliably for all patients — it varies by cancer type, age, prior treatment history, and other factors. ASCO and ICMR guidance recognises second primary cancers as a known occurrence in people who have already had one cancer. PET-CT has improved early detection by revealing these findings before symptoms appear.
Did you know?
People who have had one cancer have a higher lifetime likelihood of developing a second, unrelated primary — from a combination of shared risk factors, prior treatment effects, and in some cases inherited biology.
Whole-body PET-CT finds these second primaries incidentally, often at an earlier stage than would otherwise be possible.
Source: ASCO and ICMR guidance on second primary tumours and cancer survivorship
CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city — including an oncologist-reviewed report and a free Rs 950 consultation. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
Is a bright area on PET-CT definitely a second cancer?
No. A bright area means the tissue is taking up the radiotracer more actively than surrounding tissue, which can happen in cancer, but also in inflamed tissue, infection, and some benign conditions. A PET-CT finding is a signal that needs further investigation, not a confirmed diagnosis. Your oncologist will recommend a biopsy or additional imaging to establish what the finding actually is before any new plan is made.
How is a second primary cancer different from the first cancer spreading?
A second primary tumour starts independently in a different organ — it is not the first cancer extending into new territory. The distinction matters because spread and a second primary are staged differently and have different treatment implications. A biopsy of the new lesion is usually what confirms which situation you are in, because the cell type of the tissue provides the answer.
How common is it for a PET-CT to find a second cancer?
There is no single figure that applies to all patients. The likelihood depends on the cancer types involved, your age, prior treatment history, and other factors. ASCO and ICMR guidance acknowledges second primary cancers as a recognised occurrence in people who have already had one cancer, and whole-body PET-CT has increased the rate at which they are detected at an early stage. Your oncologist can give you a more meaningful picture based on your specific situation.
Will both cancers be treated at the same time?
Not necessarily. Whether treatment runs concurrently or is sequenced depends on what each cancer is, how advanced each is, and whether the treatments are compatible. Some regimens can be given together safely; others need to be separated because of toxicity or urgency. This is the kind of decision that goes to a multidisciplinary team meeting, where specialists in both cancer types contribute to the plan.
Should we get a second opinion?
Asking for a second opinion on a complex finding like this is entirely reasonable, and no oncologist should object to it. The most useful second opinion is usually on the biopsy pathology, which is the definitive document, and on the proposed treatment plan once both cancers are confirmed and staged. Bring your imaging reports and pathology results to any second opinion appointment.
What should we ask at the next appointment?
Ask four things: whether a biopsy or further imaging has been arranged for the new lesion, and when; when the case will go to a multidisciplinary team meeting; if the second finding is confirmed as cancer, what its type and stage are; and how treatment for both cancers will be coordinated. Writing the answers down during the appointment helps — these conversations are hard to hold in memory when you are frightened.